Latest News and Press Releases
Want to stay updated on the latest news?
-
PHOENIX, AZ, July 31, 2025 (GLOBE NEWSWIRE) -- Walter P Moore has expanded into Phoenix, Arizona, enhancing its ability to deliver innovative engineering solutions in one of the nation’s...
-
MCLEAN, Va., July 23, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion”), a leader in innovative, high-margin cybersecurity solutions, attended the National Association of County...
-
Aztiq sells Adalvo, one of the leading business-to-business pharmaceutical companies in Europe founded in 2018, to EQT, a global investment organization.
-
MCLEAN, Va., July 11, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion”), a leader in IT cybersecurity solutions and AI, today announced that Michael A. Phillips, Vice President of...
-
REYKJAVÍK (10. JÚLÍ 2025) - Alvotech (NASDAQ: ALVO) hefur skipað Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs. Linda er reyndur alþjóðlegur stjórnandi á sviði rekstrar og fjármála. Hún...
-
REYKJAVIK, ICELAND (July 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced...
-
Robbins LLP is Investigating Allegations that Centene Corporation (CNC) Misled Investors Regarding its Business Prospects
-
REYKJAVIK, ISLAND UND BURGDORF, SCHWEIZ (9. JULI 2025) — Alvotech (NASDAQ: ALVO), ein globales Biotech-Unternehmen, das sich auf die Entwicklung und Herstellung von Biosimilars für Patienten weltweit...
-
REYKJAVIK, ISLAND OCH BURGDORF, SCHWEIZ (9 JULI 2025) — Alvotech (NASDAQ: ALVO SDB), ett globalt biofarmaceutiskt företag som specialiserar sig på utveckling och tillverkning av biosimilära...
-
REYKJAVIK, ICELAND AND BURGDORF, SWITZERLAND (JULY 9, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...